“…Given that the relative prevalence of NSTEMI versus STEMI has been increasing globally, the prognostic impact of NSTEMI presentation may be even more important in the current era. Indeed, it is conceivable that the present study population represents a contemporary PCI population, with the use of intravascular ultrasound, drug-eluting stents, and MCS in 98.0%, 87.2%, and 56.6%, respectively, which is in line with current clinical practice patterns in Japan [ 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 ].…”